Article
Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jan 2017
Geurts-Giele Willemina R R, van Verschuer Victorien M T, van Deurzen Carolien H M, van Diest Paul J, Pedrosa Rute M S M, Collée J Margriet, Koppert Linetta B, Seynaeve Caroline, Dinjens Winand N M
Abstract excerpt
Female BRCA1/2 mutation carriers affected with breast and/or ovarian cancer may develop new tumor deposits over time. It is of utmost importance to know the clonal relationships between multiple tumor localizations, enabling differentiation between multiple primaries or metastatic disease with consequences for therapy and prognosis. We evaluated the value of targeted next generation sequencing in the diagnostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.